Pfizer now expects approximately $55 billion in combined revenues for its Covid-19 vaccine and antiviral in 2022, and what would be a record high overall revenue of between $98 billion and $102 billion.
Pfizer’s 2022 revenue guidance range was slightly below the FactSet consensus estimate of $103.2 billion. Pfizer expects $32 billion in revenue from Comirnaty, below the FactSet consensus estimate of $34.8 billion, and $22 billion in revenue for Paxlovid, in line with the $22 billion FactSet consensus estimate.
Sales of the company’s blockbuster pneumococcal vaccines, Prevnar 13 and Prevnar 20, were down 25% to $1.3 billion globally in the fourth quarter, a drop the company attributed to unfavorable timing of government purchases in the U.S. The company’s chief scientific officer, Mikael Dolsten, said that Pfizer is planning to start human trials for an improved version of its antiviral in the second half of 2022.
NOW you know why they support unethical vax mandates, $$$$. If you think it's concern for patients, you're clueless. Watch dopesick, it's a good interpretation of where the big pharmas priorities are.. hint: $$$
What a surprise
Blimey ! The sick & paranoid are making Pfizer very rich ! Apparently making a profit of around £20 for every jab they manufacture. I can name at least one company that would like this pandemic to go on forever.
Literally all about money. How about it’s “effectiveness”? Y’all not preaching about that.
Man, how do they do it?
South Africa South Africa Latest News, South Africa South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: WSJ - 🏆 98. / 63 Read more »